Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 2.700
-0.100 (-3.57%)
At close: Mar 13, 2026
Arterra Bioscience Market Cap
Arterra Bioscience has a market cap or net worth of €17.98 million as of March 13, 2026. Its market cap has increased by 36.36% in one year.
Market Cap
17.98M
Enterprise Value
14.99M
Revenue
4.17M
Ranking
n/a
PE Ratio
13.45
Stock Price
€2.70
Market Cap Chart
Since October 28, 2019, Arterra Bioscience's market cap has decreased from 22.33M to 17.98M, a decrease of -19.48%. That is a compound annual growth rate of -3.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 17.98M | -10.60% |
| Dec 30, 2025 | 20.11M | 54.08% |
| Dec 30, 2024 | 13.05M | 18.07% |
| Dec 29, 2023 | 11.05M | -23.15% |
| Dec 30, 2022 | 14.38M | -24.57% |
| Dec 30, 2021 | 19.07M | 1.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 9.30B |
| DiaSorin | 3.45B |
| Amplifon | 2.31B |
| EL.En. | 1.02B |
| Garofalo Health Care | 463.74M |
| Health Italia | 56.09M |
| Svas Biosana | 43.78M |
| Talea Group | 40.74M |